Noble Health Services, INC.

Noble Health Services, INC. was paid $27K by Medicaid between May 2018 and Nov 2024, across 7 billing codes. Its largest line is A9276, Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply — 56% of everything it billed.

33Billing provider infoNOBLE HEALTH SERVICES, INC.
SYRACUSE, NY 13206

33aNPI1750626453assigned 12/06/2012

33bProvider typeSpecialty Pharmacy

28Total paid$27K

24GClaims4,904

24DCodes billed7

24AFirst – last monthMay 2018 – Nov 2024

Compared with peers

Next to other Specialty Pharmacy providers in New York

Rank by total paid#6 of 11

Median peer was paid$27K

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	620	$0.00
2019	1,178	$6K
2020	1,176	$18K
2021	800	$1K
2022	289	$374.84
2023	340	$0.00
2024incomplete	501	$399.46

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
A9276	Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply	56%	41	40	$15K
A9277	Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system	27%	12	12	$7K
J7507	Tacrolimus, immediate release, oral, 1 mg	13%	1,271	976	$3K
J7518	Mycophenolic acid, oral, 180 mg	4.2%	75	73	$1K
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	<1%	1,546	1,480	$127.80
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	<1%	1,946	1,243	$32.84
J7517	Mycophenolate mofetil, oral, 250 mg	<1%	13	13	$17.28

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMEEKS, KATIE (DIRECTOR OF PHARMACY OPERATIONS)

Same official

Other billing entities under MEEKS, KATIE

Full network →

Provider	Location	Paid
Noble Health Services, INC.	Flowood, MS	$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.